WHO ICTRP trial

A study to evaluate the efficacy of Svarnsaathi (a proprietary formulation…

CTRI/2018/10/015878 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2018/10/015878
Public title A study to evaluate the efficacy of Svarnsaathi (a proprietary formulation enriched with curcumin) in the treatment of Oral Sub-Mucous Fibrosis
Scientific title A Randomized Multicentric, Placebo-controlled, Parallel, Double-blinded clinical trial to evaluate the efficacy of Svarnsaathi (a proprietary formulation enriched with curcumin) in the treatment of Oral Sub-Mucous Fibrosis - OSMF
Primary sponsor BigBrother Nutra Care Pvt Ltd
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Countries India
Conditions Health Condition 1: M265- Dentofacial functional abnormalities
Interventions Intervention1: Svarnsaathi, 4g sachets: The product is a natural product and intended for the mild to moderate oral sub-mucous fibrosis symptoms relief. To be taken orally once in morning daily for 3months Control Intervention1: Placebo…
Registration date Mar 10, 2018
Target size 50
Secondary IDs NIL
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations